SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056223
Filing Date
2021-11-10
Accepted
2021-11-10 16:27:57
Documents
75
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cccc-10q_20210930.htm   iXBRL 10-Q 3157509
2 EX-31.1 cccc-ex311_8.htm EX-31.1 20652
3 EX-31.2 cccc-ex312_6.htm EX-31.2 20663
4 EX-32.1 cccc-ex321_7.htm EX-32.1 9388
5 EX-32.2 cccc-ex322_9.htm EX-32.2 9285
  Complete submission text file 0001564590-21-056223.txt   9611783

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cccc-20210930.xsd EX-101.SCH 64786
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cccc-20210930_cal.xml EX-101.CAL 55976
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cccc-20210930_def.xml EX-101.DEF 153673
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cccc-20210930_lab.xml EX-101.LAB 443110
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cccc-20210930_pre.xml EX-101.PRE 329319
11 EXTRACTED XBRL INSTANCE DOCUMENT cccc-10q_20210930_htm.xml XML 1680233
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39567 | Film No.: 211397089
SIC: 2836 Biological Products, (No Diagnostic Substances)